The FDA has recently sent out a warning to physicians who use compounded drugs produced by Unique Pharmaceuticals. According to an FDA spokeswoman, FDA inspectors discovered issues in the facility of the manufacturer that could lead to the contamination of medications. It is believed that possible unsanitary conditions were found in production areas that yield sterile drugs. These drugs are specially formulated for and shipped to doctors nationwide and could possibly affect patients in Connecticut.
It has been reported that patients who use these possibly contaminated drugs could suffer from adverse medical events, including developing a serious infection. Because of this, a recall was issued for all sterile products that are not expired. One of the drugs believed to be affected is a fluid used to help patients that suffer from respiratory issues.